EZH2 and neoplasm: In a mouse model study, BAP loss resulted in an increase in EZH2 and PCR2, and BAP1 loss cells were sensitive to EZH2 inhibition, providing evidence for the potential role of BAP1 in mediating tumor sensitivity of EZH2 inhibition [75].